HopeStage
Back to all studies
Enrolling By InvitationNCT07217977

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

Observational studyAges 6–60United States
The study in practice

Understand this study

Who could participate?

This study is for people with ADHD. Listed age limits: 6 years to 60 years. Other eligibility criteria apply.

Listed locations
Mobile and 6 more locationsSee all locations and recruitment

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: January 15, 2025
Recruitment status
Enrolling By Invitation
Enrollment listed in the registry
175
Sponsor
Qbtech AB
Sponsor type
Unknown or unclear
Study type
Observational
Intervention type
OTHER
Study phase
Not clearly listed
Locations
United States
Age range
From 6 Years to 60 Years
Official registry ID
NCT07217977
Official title
Show the full official title

An Investigational Study Examining the Efficacy of QbMobile in Treatment Monitoring in Individuals With ADHD

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

By invitation

Mobile · San Jose · Largo

4 more locations
  • Miami
  • Orlando
  • Goldsboro
  • Dallas

A listed location does not confirm current availability.

FAQ

Questions about this study

Who is behind this study?

The study sponsor is Qbtech AB.

Who can participate?

This study is for people with ADHD. Listed age limits: 6 years to 60 years. Other eligibility criteria apply.

Is this study still recruiting?

The registry lists this study as enrolling by invitation.

Want to explore more studies?

Explore studies